Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
Latest Deal Type
Latest Deal Amount
Vidasym General Information
Operator of a clinical-stage company intended to cure chronic kidney disease. The company is developing small molecule drugs primarily for renal disorders, providing patients to get relief from diseases.